Why is Medico Remedies falling/rising?
As of 04-Sep, Medico Remedies Ltd is priced at 39.15, down 2.27%, and has underperformed its sector today. Despite strong financial metrics, concerns arise from a decline in promoter confidence and significant underperformance relative to the broader market.
As of 04-Sep, Medico Remedies Ltd is currently priced at 39.15, reflecting a decline of 0.91, or 2.27%. The stock has underperformed its sector by 2.12% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In the past week, the stock has shown a slight increase of 0.93%, but over the past month, it has decreased by 2.03%. Notably, the delivery volume has significantly dropped by 71.48% compared to the 5-day average, indicating reduced investor participation. Although the company has demonstrated strong financial metrics, such as a low Debt to EBITDA ratio and healthy operating profit growth, the recent decrease in promoter confidence, with a 1.2% reduction in their stake, raises concerns about future performance.Broader market context shows that while Medico Remedies has underperformed the market over the past year, with a return of -14.72% compared to the BSE500's -4.38%, it has outperformed the benchmark in the short term, gaining 0.93% over the last week against the Sensex's 0.80%. Despite the company's positive financial indicators, including a growing PAT and net sales, the overall sentiment appears to be negative due to the declining promoter stake and the stock's significant underperformance relative to the broader market. This combination of factors contributes to the stock's current downward movement.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
